Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1985 1
1986 2
1987 3
1988 2
1989 2
1990 2
1994 9
1995 8
1996 15
1997 32
1998 37
1999 54
2000 51
2001 66
2002 98
2003 91
2004 95
2005 116
2006 137
2007 90
2008 123
2009 131
2010 125
2011 134
2012 139
2013 138
2014 118
2015 122
2016 138
2017 128
2018 139
2019 150
2020 155
2021 148
2022 161
2023 135
2024 109

Text availability

Article attribute

Article type

Publication date

Search Results

2,878 results

Results by year

Filters applied: . Clear all
Page 1
A review of the pharmacological and clinical profile of mirtazapine.
Anttila SA, Leinonen EV. Anttila SA, et al. CNS Drug Rev. 2001 Fall;7(3):249-64. doi: 10.1111/j.1527-3458.2001.tb00198.x. CNS Drug Rev. 2001. PMID: 11607047 Free PMC article. Review.
This dual mode of action may conceivably be responsible for mirtazapine's rapid onset of action. Mirtazapine is extensively metabolized in the liver. ...In contrast to selective serotonin reuptake inhibitors (SSRIs), mirtazapine has no sexual side effe …
This dual mode of action may conceivably be responsible for mirtazapine's rapid onset of action. Mirtazapine is extensi …
Pharmacotherapy for post traumatic stress disorder (PTSD).
Williams T, Phillips NJ, Stein DJ, Ipser JC. Williams T, et al. Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD002795. doi: 10.1002/14651858.CD002795.pub3. Cochrane Database Syst Rev. 2022. PMID: 35234292 Free PMC article. Review.
For this outcome we also found evidence of beneficial effect for the noradrenergic and specific serotonergic antidepressant (NaSSA) mirtazapine: (RR 0.45, 95% CI 0.22 to 0.94; 1 study, 26 participants) in 65% of people on mirtazapine compared with 22% of placebo par …
For this outcome we also found evidence of beneficial effect for the noradrenergic and specific serotonergic antidepressant (NaSSA) mirta …
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Kishi T, Ikuta T, Sakuma K, Okuya M, Hatano M, Matsuda Y, Iwata N. Kishi T, et al. Mol Psychiatry. 2023 Jan;28(1):402-409. doi: 10.1038/s41380-022-01824-z. Epub 2022 Oct 17. Mol Psychiatry. 2023. PMID: 36253442 Free PMC article.
The meta-analysis comprised 34 studies (n = 9384, mean age = 43.80 years, and %females = 68.10%) on 20 antidepressants (agomelatine, amitriptyline, bupropion, citalopram, desvenlafaxine, duloxetine, escitalopram, fluoxetine, fluvoxamine, levomilnacipran, milnacipran, mirtazapi …
The meta-analysis comprised 34 studies (n = 9384, mean age = 43.80 years, and %females = 68.10%) on 20 antidepressants (agomelatine, amitrip …
Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.
Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G. Furukawa TA, et al. Lancet Psychiatry. 2019 Jul;6(7):601-609. doi: 10.1016/S2215-0366(19)30217-2. Epub 2019 Jun 6. Lancet Psychiatry. 2019. PMID: 31178367 Free PMC article.
Venlafaxine (16 treatment groups) had an initially increasing dose-efficacy relationship up to around 75-150 mg, followed by a more modest increase, whereas for mirtazapine (11 treatment groups) efficacy increased up to a dose of about 30 mg and then decreased. Both venlaf …
Venlafaxine (16 treatment groups) had an initially increasing dose-efficacy relationship up to around 75-150 mg, followed by a more modest i …
Mirtazapine in Cancer-Associated Anorexia and Cachexia: A Double-Blind Placebo-Controlled Randomized Trial.
Hunter CN, Abdel-Aal HH, Elsherief WA, Farag DE, Riad NM, Alsirafy SA. Hunter CN, et al. J Pain Symptom Manage. 2021 Dec;62(6):1207-1215. doi: 10.1016/j.jpainsymman.2021.05.017. Epub 2021 May 26. J Pain Symptom Manage. 2021. PMID: 34051293 Clinical Trial.
Mirtazapine was associated with significantly less increase in depressive symptoms and higher prevalence of somnolence. The change in other outcomes did not differ significantly between mirtazapine and placebo. CONCLUSION: Mirtazapine 15mg at night for 28 day …
Mirtazapine was associated with significantly less increase in depressive symptoms and higher prevalence of somnolence. The change in …
Clinical Management of Bleeding Risk With Antidepressants.
Bixby AL, VandenBerg A, Bostwick JR. Bixby AL, et al. Ann Pharmacother. 2019 Feb;53(2):186-194. doi: 10.1177/1060028018794005. Epub 2018 Aug 6. Ann Pharmacother. 2019. PMID: 30081645 Review.
Antidepressants with low or no affinity for the serotonin transporter, such as bupropion or mirtazapine, may be appropriate alternatives for patients at risk of bleeding. ...
Antidepressants with low or no affinity for the serotonin transporter, such as bupropion or mirtazapine, may be appropriate alternati …
Mirtazapine as Appetite Stimulant in Patients With Non-Small Cell Lung Cancer and Anorexia: A Randomized Clinical Trial.
Arrieta O, Cárdenas-Fernández D, Rodriguez-Mayoral O, Gutierrez-Torres S, Castañares D, Flores-Estrada D, Reyes E, López D, Barragán P, Soberanis Pina P, Cardona AF, Turcott JG. Arrieta O, et al. JAMA Oncol. 2024 Mar 1;10(3):305-314. doi: 10.1001/jamaoncol.2023.5232. JAMA Oncol. 2024. PMID: 38206631 Clinical Trial.
OBJECTIVES: To assess the effect of mirtazapine on appetite and energy consumption in patients with advanced non-small cell lung cancer (NSCLC). ...Fats intake was significantly higher in patients in the mirtazapine group (14.5 g vs 0.7 g; P = .02) after 8 weeks. Th …
OBJECTIVES: To assess the effect of mirtazapine on appetite and energy consumption in patients with advanced non-small cell lung canc …
Mirtazapine-Associated Prostatism.
Naguy A, Alsumaiti A, Alamiri B. Naguy A, et al. Am J Ther. 2023 Jul-Aug 01;30(4):e399-e400. doi: 10.1097/MJT.0000000000001473. Epub 2022 Jan 10. Am J Ther. 2023. PMID: 35104061 No abstract available.
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial.
Banerjee S, High J, Stirling S, Shepstone L, Swart AM, Telling T, Henderson C, Ballard C, Bentham P, Burns A, Farina N, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Tabet N. Banerjee S, et al. Lancet. 2021 Oct 23;398(10310):1487-1497. doi: 10.1016/S0140-6736(21)01210-1. Lancet. 2021. PMID: 34688369 Free PMC article. Clinical Trial.
The number of controls with adverse events (65 [64%] of 102 controls) was similar to that in the mirtazapine group (67 [66%] of 102 participants receiving mirtazapine). ...INTERPRETATION: This trial found no benefit of mirtazapine compared with placebo, and w …
The number of controls with adverse events (65 [64%] of 102 controls) was similar to that in the mirtazapine group (67 [66%] of 102 p …
Efficacy and Safety of Appetite-Stimulating Medications in the Inpatient Setting.
Howard ML, Hossaini R, Tolar C, Gaviola ML. Howard ML, et al. Ann Pharmacother. 2019 Mar;53(3):261-267. doi: 10.1177/1060028018802816. Epub 2018 Sep 19. Ann Pharmacother. 2019. PMID: 30229678
Conclusion and Relevance: In inpatients, there was no difference in change in meal intake or weight between dronabinol, megestrol, or mirtazapine, but they may show numerical improvements in meal intake. To our knowledge, this is the first study to evaluate the use of dron …
Conclusion and Relevance: In inpatients, there was no difference in change in meal intake or weight between dronabinol, megestrol, or mir …
2,878 results